Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Financings in Brief: Furon extends tender offer for Medex

This article was originally published in The Gray Sheet

Executive Summary

Furon extends tender offer for Medex: Furon's $23.50 per share tender offer for Medex stock, announced in November ("The Gray Sheet" Nov. 18, p. 8), is extended until 5 p.m. EST on Jan. 2, 1997. The offer had been set to expire on Dec. 19. Shortly before the earlier deadline, Furon reported that 5.1 mil. Medex shares had been tendered under the offer. Those shares, combined with shares agreed to be tendered by Medex management, represent about 82.3% of Medex' total outstanding common stock -- enough, Furon says, to enact the merger on a "short form" basis...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007293

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel